Difference between revisions of "Talk:Assessment of the health impacts of H1N1 vaccination/Group E"
(technical edits) |
|||
(8 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
[[Category:DARM exercise]] | [[Category:DARM exercise]] | ||
== Pandemrix should not be used because of narcolepsy risk == | == Pandemrix should not be used because of narcolepsy risk == | ||
+ | |||
+ | Anna, Sallamari | ||
{{discussion | {{discussion | ||
|Statements= Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010. | |Statements= Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010. | ||
− | |Resolution= | + | |Resolution= Not accepted mainly because risks are small and benefits high. |
|Argumentation = | |Argumentation = | ||
− | |||
− | {{ | + | {{attack|J1 |Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}} |
− | + | ||
− | + | {{defend invalid|J2 |The reputation of Pandemrix is globally so poor that it is impossible to use it any more.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}} | |
− | + | ||
− | + | :{{attack|E9 |The information supplied on the safety and effectiveness of three of the pandemic-influenza vaccines was considered complete enough for the Agency's Committee for Medicinal Products for Human Use to recommend their use outside a pandemic situation. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST)}} <ref name="emaswineflu">[http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801d7bfe&jsenabled=true European Medicines Agency (EMA)]: Information page on Swine flu</ref> | |
− | |||
− | |||
− | {{ | + | ::{{comment|# |I am not sure if this is a convincing argument about reputation. However, you may want to create a new argument about the safety of Pandemrix, and then it would be defended by this argument.|--[[User:Jouni|Jouni]] 08:15, 2 April 2011 (EEST)}} |
− | {{attack| | + | :{{defend|J3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST)}} <ref name="thl20100825">[http://www.thl.fi/en_US/web/en/pressrelease?id=22930 THL press release 25 Aug 2010]</ref> |
+ | |||
+ | {{attack|E6 |The vaccination used last year will most likely protect also against the possible swine flu epidemic of this year, although the virus has changed a bit.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:57, 1 April 2011 (EEST)}} <ref name="thl20101209">[http://www.thl.fi/fi_FI/web/fi/uutinen?id=23692 THL press release 9 Dec 2010]</ref> | ||
+ | |||
+ | :{{comment|# |This may be true but what is the connection to the statement?|--[[User:Jouni|Jouni]] 08:15, 2 April 2011 (EEST)}} | ||
+ | |||
+ | :{{defend|E7 |Vaccination is a very good method of preventing swine flu infections.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:59, 1 April 2011 (EEST)}} <ref name="thl20101209"/> | ||
+ | |||
+ | :{{defend|E8 |WHO recommended that H1N1 virus strain be included in the seasonal flu vaccines for the 2009/2010 season, because H1N1 is still in circulation, but behaving like a seasonal flu virus. |--[[User:Anna Kokkonen|Anna Kokkonen]] 11:10, 1 April 2011 (EEST)}} <ref name="emaswineflu"/> | ||
+ | |||
+ | {{attack|E4 |The side effects of Pandemrix have been accentuated, although the benefits are much more significant.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:50, 1 April 2011 (EEST)}} <ref name="hsarkkiatri">[http://www.hs.fi/kotimaa/artikkeli/MTV3+Arkkiatri+moittii+sikainfluenssarokotteen+vastustajia/1135250236010 Helsingin Sanomat]: Arkkiatri moittii sikainfluenssarokotteen vastustajia (in Finnish)</ref> | ||
+ | |||
+ | {{attack|E5 |Nursing staff in hospitals should be vaccinated; it is their responsibility as medical professionals.|--[[User:Sallamari Tynkkynen|Sallamari Tynkkynen]] 10:54, 1 April 2011 (EEST)}} <ref name="hsarkkiatri"/> | ||
+ | |||
+ | :{{comment|# |This may be true but what is the connection to the statement? Does this actually relate more to E4 than the main statement?|--[[User:Jouni|Jouni]] 08:15, 2 April 2011 (EEST)}} | ||
}} | }} | ||
+ | |||
+ | ==See also== | ||
*[http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801d7bfe&jsenabled=true European Medicines Agency (EMA) information page on Swine flu] | *[http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000461.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac05801d7bfe&jsenabled=true European Medicines Agency (EMA) information page on Swine flu] | ||
*[http://www.hs.fi/kotimaa/artikkeli/MTV3+Arkkiatri+moittii+sikainfluenssarokotteen+vastustajia/1135250236010] | *[http://www.hs.fi/kotimaa/artikkeli/MTV3+Arkkiatri+moittii+sikainfluenssarokotteen+vastustajia/1135250236010] | ||
*[http://www.thl.fi/fi_FI/web/fi/uutinen?id=23692] | *[http://www.thl.fi/fi_FI/web/fi/uutinen?id=23692] | ||
+ | |||
+ | ==References== | ||
+ | |||
+ | <references/> |
Latest revision as of 08:26, 6 April 2011
Pandemrix should not be used because of narcolepsy risk
Anna, Sallamari
Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.
Resolution: Not accepted mainly because risks are small and benefits high. (A stable resolution, when found, should be updated to the main page.) |
Argumentation:
⇤J1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST) ←J2 The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST)
⇤E6 : The vaccination used last year will most likely protect also against the possible swine flu epidemic of this year, although the virus has changed a bit. --Sallamari Tynkkynen 10:57, 1 April 2011 (EEST) [3]
⇤E4 : The side effects of Pandemrix have been accentuated, although the benefits are much more significant. --Sallamari Tynkkynen 10:50, 1 April 2011 (EEST) [4] ⇤E5 : Nursing staff in hospitals should be vaccinated; it is their responsibility as medical professionals. --Sallamari Tynkkynen 10:54, 1 April 2011 (EEST) [4]
|
See also
References
- ↑ 1.0 1.1 European Medicines Agency (EMA): Information page on Swine flu
- ↑ THL press release 25 Aug 2010
- ↑ 3.0 3.1 THL press release 9 Dec 2010
- ↑ 4.0 4.1 Helsingin Sanomat: Arkkiatri moittii sikainfluenssarokotteen vastustajia (in Finnish)